Based on the data provided, Acme United Corp (ACU) does not present a strong buy opportunity for a beginner investor with a long-term strategy. While the company has shown some growth in revenue and international sales, the lack of significant trading trends, neutral insider and hedge fund sentiment, and no strong proprietary trading signals suggest that this stock is better suited for holding rather than immediate purchase.

Technical Analysis

The technical indicators show a bullish trend with the MACD above 0 and positively expanding, and the moving averages (SMA_5 > SMA_20 > SMA_200) confirming a bullish alignment. However, the RSI is in the neutral zone at 72.765, suggesting no clear overbought or oversold conditions. The stock is trading near its resistance level (R1: 45.987), which may limit immediate upside potential.

Positive Catalysts

The company reported record sales of $196.5 million for Q4 2025, with a 3% YoY increase in revenue and a 31% increase in European net sales driven by strong performance in the first aid product segment.

Neutral/Negative Catalysts

Net income and EPS have declined YoY in Q3 2025, with net income dropping by 14.51% and EPS by 14.81%. Insider and hedge fund trading sentiment is neutral, and there are no significant trading trends.

Financial Performance

For Q4 2025, the company reported revenue of $47.5 million, a 3% YoY increase, and net income of $1.9 million. However, in Q3 2025, net income dropped by 14.51% YoY, and EPS decreased by 14.81%, indicating mixed financial performance.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target data available.

Analyst Rating

Wall Street analysts forecast ACU stock price to rise

Buy

Hold

Sell

Current: 45.010

Low

Averages

High